Targeting Bacterial ÏsuperbugsÍ By Innovative Combination Dosing Strategies And New Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$463,650.00
Summary
This research project will elucidate the mechanistic basis to optimally combine available beta-lactam antibiotics to prevent resistance of gram-negative bacterial ïsuperbugsÍ. These mechanistic insights will be utilised to develop novel antibiotics that are active against these multidrug-resistant bacteria. The interdisciplinary project will substantially contribute to solving the global crisis due to multidrug-resistant bacteria and inform the design of effective new antibiotics.
Using Mathematical Models Of Infection To Inform The Design And Analysis Of Epidemiologic Studies.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Childhood immunisation has been enormously successful at preventing death and disease. Not all vaccines provide life-long protection, however, and booster doses may be required for older children or even adults. Deciding when and how often doses are required depends on how a particular infection is spread within families and the community both before and after vaccine use. We want to understand more about this process and its implications for the ongoing effectiveness of vaccine programs.
Pathophysiology And Therapeutics Of Lipoprotein Disorders In Humans
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
Lipid disorder is the major casual factor that contributes to the development of cardiovascular disease, the leading cause of death in Australia. My research has provided new knowledge that has significant impact upon the treatment strategy of lipid disorder and cardiovascular risk. My vision for the next four years is to develop a comprehensive program in understanding lipid transport and translating the knowledge into clinical practice.
Using Modelling To Evaluate STI Epidemiology Control Strategies And Investigate Chlamydial Within-host Disease
Funder
National Health and Medical Research Council
Funding Amount
$94,250.00
Summary
This research will further our understanding of the mechanisms that give rise to the development of Chlamydia within a cell and how it causes disease, ultimately providing targets for drug-vaccine design. This project will also design and evaluate epidemic control strategies to inform policy makers for reducing the incidence and prevalence of sexually transmitted infections. These applications are addressed by developing mathematical models, biophysical theory, and statistical analyses.
Combating Bacterial 'superbugs' By Innovative Antibiotic Combination Strategies
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
Resistant bacteria are among the 3 most serious threats to human health. This project will substantially improve our quantitative understanding of how bacteria survive antibiotics and enable the design of innovative antibiotic combination therapies to combat resistant ‘superbugs’. My research outcomes will inform clinicians how to optimally use available antibiotics and greatly support rational development and optimisation of new antibiotics in collaboration with pharmaceutical industry.
Understanding And Preventing Population-level Harm From Alcohol
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
This project will support Dr Livingston's world-leading work to better understand the reasons that alcohol consumption and related-harm changes at the population level. It will also support projects that will directly assess the impact of changes to alcohol policies in Australia and the development of policy simulation models, to provide critical evidence and ensure well-informed policy decisions can be made to reduce alcohol-related harm.
Evaluation Of New Screening Strategies For Prevention Of Cancer
Funder
National Health and Medical Research Council
Funding Amount
$251,144.00
Summary
Governments, clinicians and consumers have a need for accurate and up-to-date information about the cost-effectiveness, benefits and harms of cancer screening. This project will evaluate whether further changes to cervical screening will be needed after the release of next generation HPV vaccines, whether new screening programs should be implemented for lung cancer and Lynch syndrome, the potential role of new technologies for bowel screening, and whether prostate testing can be improved.
Patient-specific Modelling Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Cardiovascular disease is undoubtedly the biggest killer in the developed world and accounts for 30% of all deaths in Australia; killing one Australian every twelve minutes. My research group and I, combine medical imaging with biomedical engineering to perform patient-specific modelling. For example, we can predict the likelihood that aneurysm will rupture or the way blood flows through the aorta. My goal is to make these modelling tools accurate and robust enough to be used in the clinic.